Cryo-Cell receives Nasdaq notice for audit committee non-compliance; cure period until Sept 2022

CRYO CELL INTERNATIONAL INC

Nasdaq notified that audit committee has only 2 independent members, needs 3 per Rule 5605.
Cure period: earlier of next annual meeting or September 20, 2022 (or March 21, 2022 if meeting before that).
Company must submit documentation evidencing compliance by the cure deadline.
Cryo-Cell states it is working diligently to regain compliance within the cure period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.